日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nuclear factor κ-light chain-enhancer of activated B cells is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiotheraphy

活化 B 细胞的核因子 κ 轻链增强子可通过放射治疗激活,并且可预测接受术前氟尿嘧啶为基础的放化疗治疗的直肠癌患者的总体生存率

Bert H O'Neil, William K Funkhouser, Benjamin F Calvo, Michael O Meyers, Hong Jin Kim, Richard M Goldberg, Stephen A Bernard, Laura Caskey, Allison M Deal, Fred Wright, Albert S Baldwin, Joel E Tepper

Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapy

磷酸化 ERK 和 AKT 状态(而非 KRAS 突变状态)与接受放化疗治疗的直肠癌的预后相关

Janine M Davies, Dimitri Trembath, Allison M Deal, William K Funkhouser, Benjamin F Calvo, Timothy Finnegan, Karen E Weck, Joel E Tepper, Bert H O'Neil